All Posts By

eliselcv

Brainvectis gave oral presentations at the European Society of Gene and Cell Therapy (ESGCT) conference

By | Non classé | No Comments

Brainvectis will participate in the European Society of Gene and Cell Therapy, that will be held at Lausanne, Switzerland.

Nathalie Cartier will give an oral presentation on Tuesday 16th October during the CNS session entitled « Gene Therapy for Huntington’s disease ».

Sandro Alves will give an oral presentation on friday 19th October during the CNS session entitled « CYP46A1 gene therapy alleviates spinocerebellar ataxia in mouse models ».

 

Brainvectis at the Gene Therapy partnering day

By | Non classé | No Comments

Sandro Alves participated in the Gene Therapy partnering day, held at the Institut des Maladies Génétiques, organized by Medicen/Imagine (Paris). Sandro Alves introduced Brainvectis in the session « Innovative Technological Solutions » as an example of start-up translating academic preclinical research into industrial development.

 

Brainvectis at NeurATRIS annual meeting 2017

By | Non classé | No Comments

On november 21st,  Head of preclinical research Dr. Sandro Alves presented Brainvectis as an example of  spin-off translating academic preclinical research into industrial development.

NeurATRIS is a research infrastructure conceived to accelerate the translation of discoveries in basic research into medical innovations for the treatment of diseases of the nervous system.